{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-019800","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2022-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.619435+00:00","generated_at":"2026-06-24T01:22:36.486481+00:00","sec_items":["7.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Puma Biotechnology retracts defamatory statements about Dr. Frederic Eshelman after court ruling","bullets":["Retracts 2016 investor-presentation statements implying Dr. Eshelman was fired from PPD and involved in clinical fraud.","Fourth Circuit affirmed liability verdict on June 23, 2021, but vacated excessive damages award.","Company states no portion of presentation should be interpreted to suggest Eshelman fired or implicated in fraud."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-019800","json":"https://secwatch.observer/filing/0001437749-22-019800.json","markdown":"https://secwatch.observer/filing/0001437749-22-019800.md","text":"https://secwatch.observer/filing/0001437749-22-019800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922019800/0001437749-22-019800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922019800/pbyi20220810_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:22:36.486481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}